Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
12,939,536
-
Total 13F shares
-
40,700
-
Share change
-
-314,286
-
Total reported value
-
$126,000
-
Price per share
-
$3.10
-
Number of holders
-
1
-
Value change
-
-$223,143
-
Number of sells
-
1
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) as of Q2 2023
As of 30 Jun 2023,
Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
40,700 shares.
The largest 1 holders included
AR ASSET MANAGEMENT INC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.